iPSC & ESC Lines
Applied StemCell’s iPSC catalog includes a broad range of iPS cell lines: footprint-free (episomal) and retroviral iPSC lines from different tissues (PBMCs, fibroblasts, cord blood, adipocytes) from healthy and diseased patients; iPSCs derived from mouse, pig, guinea pigs using episomal or retroviral reprogramming methods, and various mouse ESC lines that have been tested for successful germline transmission. These cells are ideal for all iPS cell culture applications such as disease modeling, differentiation into cellular lineages of choice and drug toxicity/efficacy screening.
Human induced pluripotent stem cell lines (hiPSCs) from cord blood cells, fibroblasts, and PBMCs for Disease modeling, Genome editing service, Neural differentiation panel, and Neurotoxicity screening. The control iPS lines are well characterized, and have been successfully used for genome editing and neural lineage differentiation projects.
iPSC Cells ALS8 patient and non-carrier siblings. ASC’s iPSC catalog now includes iPSCs reprogrammed from fibroblasts of 6 individual ALS8 patients and their non-affected siblings belonging to two families affected with the autosomal dominant form of familial ALS (ALS8, amyotrophic lateral sclerosis type 8).
Patient-derived human iPS cell lines: Footprint-free derived from the human somatic cells (PBMCs, fibroblasts, adipose-derived stem cells), from patients with Parkinson’s Disease (PD) and Diabetes (II); iPS Cells from ALS8 patients and non-carrier siblings.
Applied StemCell offers various iPSCs derived from mouse, pig, guinea pigs using episomal or retroviral reprogramming methods. Our catalog also includes various mouse ESCs (mESCs) that have been successfully tested for germline transmission.